Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.
Owlet, Inc. reports business developments for a pediatric health platform built around smart infant monitoring, connected wearables, video monitoring and app-based health insights. Company news commonly covers FDA-cleared pediatric monitoring products, including BabySat, consumer monitoring systems such as Dream Duo, and software services including Owlet360 and pediatric telehealth features.
Recurring updates also include quarterly financial results, guidance, leadership and governance changes, DME distribution partnerships, product recognition, and initiatives tied to Owlet's pediatric health and sleep data platform. These announcements reflect the company's mix of consumer baby monitoring, prescription monitoring access, subscriptions and connected-care services.
Owlet (NYSE: OWLT) has launched two innovations aimed at improving sleep for parents and their babies: Predictive Sleep Technology and the Owlet Cam 2. Predictive Sleep Technology utilizes the Owlet Dream Sock to automate tracking of a baby's sleep patterns, offering personalized sleep recommendations. The Owlet Cam 2 enhances the previous model with AI capabilities, providing HD video monitoring and alerts for movement and sounds. These products, designed to work in conjunction, are available at various retailers, with prices starting from $299 for the Dream Sock.
Owlet, Inc. (NYSE:OWLT) will participate in the 7th Annual Cowen FutureHealth Conference on June 22-23, 2022. CEO Kurt Workman and CFO Kate Scolnick will host a fireside chat on June 22 at 11:45 a.m. EDT. A live webcast link will be available on the Owlet Investor Relations website, along with a replay post-event. Founded in 2012, Owlet aims to support parents with timely data and insights, enhancing their parenting experience. For more details, visit owletcare.com.
Owlet, Inc. (NYSE: OWLT) will join the Russell 3000® and Russell Microcap® Indexes on June 27, 2022. This addition, announced on June 3, 2022, is seen as a significant milestone that could enhance the company's visibility within the market. CEO Kurt Workman expressed optimism about the inclusion, highlighting its potential to drive growth and shareholder value. The Russell indexes are widely recognized benchmarks for institutional investors, aiding in tracking market performance and serving as bases for index-linked products.
Owlet, Inc. reported preliminary financial results for Q1 2022, generating revenues of $21.5 million, a slight decline from $21.9 million in Q1 2021. International revenues surged, accounting for 13% of total revenues, more than doubling year-over-year. The new Dream product line launched successfully across all retail channels, enhancing brand visibility. However, the company faced challenges with operating expenses reaching $30.5 million and a net loss of $28.8 million. The gross margin fell to 40.7%, impacted by cost inflation and higher return rates.
Owlet, Inc. (NYSE: OWLT) announced its participation in the Bank of America 2022 Global Healthcare Conference from May 9-13, 2022, in Las Vegas. Executives Kurt Workman (CEO) and Kate Scolnick (CFO) will present on May 12, 2022, at 10 a.m. PDT. A live webcast will be available on the Owlet Investor Relations website, with a replay accessible afterward. Founded in 2012, Owlet aims to empower parents with real-time data for a more confident parenting journey.
Owlet, Inc. (NYSE: OWLT) will announce its first quarter 2022 results on May 11, 2022, after the market closes. The earnings release will be available via Business Wire and on the company’s Investor Relations website. CEO Kurt Workman and CFO Kate Scolnick will host a conference call at 4:30 p.m. ET to discuss the results and provide updates. Investors can join the call by phone or via a live audio webcast on the company's website. A replay will also be accessible post-event.
Summary not available.
Owlet, Inc. (NYSE: OWLT) has launched the Owlet Dream Sock Plus, an innovative sleep monitoring solution for children from birth to 5 years. Building on the success of the original Dream Sock, this device tracks sleep quality and provides personalized insights via the Owlet Dream App. Priced at $359, it includes a sensor, Base Station, and various sock sizes. The Dream Sock Plus enhances the existing product lineup, aiming to empower parents with data-driven tools for improving their child's sleep.
Owlet, Inc. (NYSE: OWLT) reported preliminary financial results for Q4 and FY2021, revealing revenues of $75.8 million and a gross profit of $35.1 million. The company faced challenges, including a $23.2 million contra-revenue adjustment due to product returns after receiving an FDA Warning Letter, leading to a net negative revenue of $2.5 million for Q4. Operating loss for Q4 reached $33.3 million. Owlet's international revenue grew over 100% year-on-year, and new product launches are expected to contribute positively in future quarters.
Owlet, Inc. (NYSE: OWLT) will participate in three investor conferences in March 2022. The events include the Cowen 42nd Annual Health Care Conference from March 7-9, the Roth 34th Annual Conference from March 13-15, and the Oppenheimer 32nd Annual Healthcare Conference from March 15-17. Co-Founder Kurt Workman and CFO Kate Scolnick will engage in fireside chats and investor meetings, with webcasts available on the Owlet website. Replay links will remain accessible for 90 days post-event. Owlet's mission is to support parents with timely information for better parenting.